In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
Mayo Clin Proc
.
2020 Dec;95(12):2802-2803.
doi: 10.1016/j.mayocp.2020.09.032.
Epub 2020 Oct 1.
Authors
Michael J Joyner
1
,
Jonathon W Senefeld
1
,
Stephen A Klassen
1
,
DeLisa Fairweather
2
,
R Scott Wright
3
,
Rickey E Carter
4
Affiliations
1
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.
2
Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL.
3
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
4
Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL.
PMID:
33276849
PMCID:
PMC7528832
DOI:
10.1016/j.mayocp.2020.09.032
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Component Transfusion / adverse effects
COVID-19 Serotherapy
COVID-19* / therapy
Coronavirus Infections* / epidemiology
Humans
Immunization, Passive
Pandemics
Plasma
SARS-CoV-2
Safety
Grants and funding
R21 AI145356/AI/NIAID NIH HHS/United States
R21 AI152318/AI/NIAID NIH HHS/United States
R21 AI154927/AI/NIAID NIH HHS/United States